1Finkel SI, Costae SJ, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: A consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr. 1996; 8 (suppl 3) : 497-500.
2Margallo LM, Swann A, O' Brien J, et al. Prevalence and pharmacological management of Behavioral psychological symptoms amongst dementia sufferers living in care environments. Int J Geriatr Psychiatry, 2001; 16: 39-44.
3Ballard CG, Margallo LM, Fossey J, et al. A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environment. J Clin Psychiaty, 2001; 62:631-636.
4Lawlor BA. Behavioral and psychological symptoms in dementia:the role of atypical antipsychotics. J Clin Psychiaty, 2004; 65(suppl 11): 5-10.
5Tariot PN, Profenno LA, Ismall MS, et al. Efficacy of atypical antipsychotics in elderly patient with dementia. J Clin Psychiaty,2004; 65 (suppl 11): 11-15.
6Katz JK, Jeste DV, Mintzer JE. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double blind trial. J Elin Psychiaty,1999; 60: 107-115.
7De Deyn PP, Rabhem K, Rasmussen A, et al. A randomized trial of risperigtone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology, 1999; 53: 946-955.
8Brodaty H, Ames D, Snowdon J, et al. A randomized placebocontrolled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiaty, 2003 ; 64 :134-143.
9Sattefiee WG, Reams SG, Bums PR, et al. A clinical update on olanzapine treatment in schizophrenia and in elderly Alzheimer's disease patients. Psychoparmacol Bull. 1995; 31 : 534.
10Steet JS, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients Alzheimer disease in nursing care facilities: A double-blind, randomized,placebo controlled trial. Arch Gen Psychiatry, 2000; 57: 968-976.
